AP-1调控p11依赖的抗抑郁反应
该研究探讨选择性5-羟色胺再摄取抑制剂(SSRI)抗抑郁反应背后的分子机制,发现由c-Fos和c-Jun组成的激活蛋白-1(AP-1)转录程序在慢性SSRI反应起效前被选择性激活。AP-1调控包括S100a10(p11)在内的神经元重塑基因表达,其功能在体内是抗抑郁效应所必需的。BDNF和FGF2通过MAPK、PI3K和JNK级联调节AP-1功能,从而介导抗抑郁反应的有益效应。
要点
- AP-1转录程序在慢性SSRI反应起效前被选择性激活,调控p11等神经重塑基因。
- AP-1功能在体内是抗抑郁效应所必需的。
- BDNF和FGF2经MAPK、PI3K和JNK级联调控AP-1以介导抗抑郁效应。
核心结论
- AP-1转录程序通过调控p11等基因将神经可塑性与抗抑郁反应联系起来,并介导SSRI的有益效应。
- 触发神经可塑性可能成为加速或增强抗抑郁反应的新途径。
研究设计与样本
- 研究采用实验性分子生物学方法,在体内外检测AP-1转录程序与慢性SSRI反应的关系。
主要发现
- 由c-Fos和c-Jun组成的AP-1复合物在慢性SSRI反应起效前被选择性激活。
- AP-1转录程序调控S100a10(p11)等关键神经元重塑基因的表达。
- AP-1功能在体内是抗抑郁效应所必需的。
- BDNF和FGF2通过MAPK、PI3K和JNK级联调节AP-1功能以介导抗抑郁有益效应。
临床怎么用
- 研究提示可通过触发神经可塑性(如靶向AP-1相关通路)来加速或增强SSRI抗抑郁反应。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Selective serotonin reuptake inhibitors (SSRIs) are the most widely prescribed drugs for mood disorders. While the mechanism of SSRI action is still unknown, SSRIs are thought to exert therapeutic effects by elevating extracellular serotonin levels in the brain, and remodel the structural and functional alterations dysregulated during depression. To determine their precise mode of action, we tested whether such neuroadaptive processes are modulated by regulation of specific gene expression programs. Here we identify a transcriptional program regulated by activator protein-1 (AP-1) complex, formed by c-Fos and c-Jun that is selectively activated prior to the onset of the chronic SSRI response. The AP-1 transcriptional program modulates the expression of key neuronal remodeling genes, including S100a10 (p11), linking neuronal plasticity to the antidepressant response. We find that AP-1 function is required for the antidepressant effect in vivo. Furthermore, we demonstrate how neurochemical pathways of BDNF and FGF2, through the MAPK, PI3K, and JNK cascades, regulate AP-1 function to mediate the beneficial effects of the antidepressant response. Here we put forth a sequential molecular network to track the antidepressant response and provide a new avenue that could be used to accelerate or potentiate antidepressant responses by triggering neuroplasticity.
引用
- Chottekalapanda RU, Kalik S, Gresack J, et al. AP-1 controls the p11-dependent antidepressant response. Mol Psychiatry. 2020. PMID: 32439846. doi:10.1038/s41380-020-0767-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。